SANTA BARBARA, Calif., April 19, 2016 -- AppFolio, Inc. (NASDAQ:APPF), today announced that it will report its first quarter 2016 financial results after the close of the U.S. Financial markets on Monday, May 9, 2016.
AppFolio will host a conference call to discuss financial results at 2:00 p.m. Pacific Time, 5:00 p.m. Eastern Time, on Monday, May 9, 2016. The conference call can be accessed by dialing 855.539.0896 and entering ID #93220882. International callers may dial 412.455.6028. A live webcast of the conference call will also be available at http://ir.appfolioinc.com.
A replay of the conference will be available beginning approximately two hours following the completion of the live call at 855.859.2056 and 404.537.3406 for International callers and will be available through May 13, 2016. An archived webcast of the conference call will be available for 12 months at http://ir.appfolioinc.com.
About AppFolio
AppFolio provides comprehensive, easy-to-use, cloud-based business software solutions for small and medium-sized businesses in various vertical markets. Our products include cloud-based property management software (AppFolio Property Manager) and cloud-based legal practice management software (MyCase). The Company was founded in 2006 and is headquartered in Santa Barbara, CA. Learn more at www.appfolioinc.com.
CONTACT: Investor Relations: Erica Abrams, [email protected], 805.364.6093


Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 



